Vivo Panda Fund, L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for Bolt Biotherapeutics, Inc. Common Stock, par value $0.00001 per share (BOLT)

Filing Manager
Vivo Panda Fund, L.P.
Reporting Manager
Vivo Capital Fund VIII, L.P.
Security
Bolt Biotherapeutics, Inc. Common Stock, par value $0.00001 per share
Symbol
BOLT
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2026, 18:48:34 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vivo Capital Fund VIII, L.P. 0% 0 0 0 /s/ Frank Kung Frank Kung/Managing Member of Vivo Capital VIII, LLC, General Partner
Vivo Capital Surplus Fund VIII, L.P. 0% 0 0 0 /s/ Frank Kung Frank Kung/Managing Member of Vivo Capital VIII, LLC, General Partner
Vivo Capital VIII, LLC 0% 0 0 0 /s/ Frank Kung Frank Kung/Managing Member
Vivo Panda Fund, L.P. 3.8% 72,414 72,414 0 /s/ Frank Kung Frank Kung/Managing Member of Vivo Panda, LLC, General Partner
Vivo Panda, LLC 3.8% 72,414 72,414 0 /s/ Frank Kung Frank Kung/Managing Member